| |
|
|
|
|
|
|
|||
|
Blood, 1 September 2006, Vol. 108, No. 5, pp. 1690-1697. Prepublished online as a Blood First Edition Paper on May 2, 2006; DOI 10.1182/blood-2005-12-012773.
Submitted December 10, 2005
Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, OH, USA * Corresponding author; email: james.mulloy{at}cchmc.org.
The t(16:16) and inv(16) are associated with FAB M4Eo
myeloid leukemias and result in fusion of the CBFB gene
to the MYH11 gene (encoding SMMHC). Knockout of CBFB
causes embryonic lethality due to lack of definitive
hematopoiesis. Although knockin of CBFB-MYH11 is not
sufficient to cause disease, expression increases the
incidence of leukemia when combined with cooperating
events. While mouse models are valuable tools in the
study of leukemogenesis, little is known about the
contribution of CBF
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2006 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||